Related Experiment Video
Updated: Jan 29, 2026
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth
Daniel W Fults1, Michael D Taylor2, Livia Garzia3
11Department of Neurosurgery, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, Utah.
Abstract:
Leptomeningeal dissemination (LMD) is the defining pattern of metastasis for medulloblastoma. Although LMD is responsible for virtually 100% of medulloblastoma deaths, it remains the least well-understood part of medulloblastoma pathogenesis. The fact that medulloblastomas rarely metastasize outside the CNS but rather spread almost exclusively to the spinal and intracranial leptomeninges has fostered the long-held belief that medulloblastoma cells spread directly through the CSF, not the bloodstream. In this paper the authors discuss selected molecules for which experimental evidence explains how the effects of each molecule on cell physiology contribute mechanistically to LMD. A model of medulloblastoma LMD is described, analogous to the invasion-metastasis cascade of hematogenous metastasis of carcinomas. The LMD cascade is based on the molecular themes that 1) transcription factors launch cell programs that mediate cell motility and invasiveness and maintain tumor cells in a stem-like state; 2) disseminating medulloblastoma cells escape multiple death threats by subverting apoptosis; and 3) inflammatory chemokine signaling promotes LMD by creating an oncogenic microenvironment. The authors also review recent experimental evidence that challenges the belief that CSF spread is the sole mechanism of LMD and reveal an alternative scheme in which medulloblastoma cells can enter the bloodstream and subsequently home to the leptomeninges.
Insights
Leptomeningeal dissemination (LMD) in medulloblastoma, a deadly cancer spread, is explored. New findings suggest cancer cells may spread via the bloodstream, not just cerebrospinal fluid (CSF).
Area of Science:
- Neuro-oncology
- Cancer Metastasis
- Molecular Biology
Background:
- Leptomeningeal dissemination (LMD) is the primary cause of medulloblastoma mortality.
- The precise mechanisms driving LMD remain poorly understood.
- Medulloblastoma typically spreads within the central nervous system (CNS), leading to the belief of cerebrospinal fluid (CSF) as the sole pathway.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying medulloblastoma LMD.
- To propose a model for medulloblastoma LMD analogous to the invasion-metastasis cascade.
- To review evidence challenging the exclusive CSF spread hypothesis.
Main Methods:
- Discussion of molecular mechanisms contributing to LMD.
- Description of a novel LMD cascade model.
- Review of experimental evidence regarding alternative metastatic pathways.
Main Results:
- Identified key molecular themes in LMD: transcription factors driving motility/invasiveness, apoptosis evasion, and inflammatory chemokine signaling.
- Proposed an LMD cascade model involving cell motility, invasiveness, stem-like states, apoptosis resistance, and microenvironment modulation.
- Presented evidence supporting a potential hematogenous (bloodstream) route for medulloblastoma metastasis to the leptomeninges.
Conclusions:
- Medulloblastoma LMD is a complex process driven by specific molecular programs.
- The traditional view of CSF-only spread is challenged by evidence of potential bloodstream dissemination.
- Understanding these mechanisms is crucial for developing targeted therapies against medulloblastoma LMD.
Related Concept Videos
01:29Oxygen Requirements and Growth Patterns
01:06Fixed Action Patterns
00:57Population Growth
01:26Patterns of Fever
02:36Meristems and Plant Growth
01:29Exponential Growth